In conclusion, considering the role of JNK3 in ND’s, the limited number of pharmacologic therapies in AD, the use of kinase inhibitors in treating other diseases, and the results of our report, FMU200 demonstrated to be a promising molecule and should be considered in further and more complex researches. Here, MAPK10 is linked to Norrie disease.